122 related articles for article (PubMed ID: 6321196)
41. Effects of meal composition on gallbladder and gastric emptying in man.
Fisher RS; Rock E; Malmud LS
Dig Dis Sci; 1987 Dec; 32(12):1337-44. PubMed ID: 3691274
[TBL] [Abstract][Full Text] [Related]
42. Physiological role of nitric oxide in gallbladder emptying in men.
Konturek JW; Konturek SJ; Pawlik T; Domschke W
Digestion; 1997; 58(4):373-8. PubMed ID: 9324165
[TBL] [Abstract][Full Text] [Related]
43. Inhibition of cholecystokinin-stimulated pancreaticobiliary output in man by the cholecystokinin receptor antagonist MK-329.
Cantor P; Olsen O; Gertz BJ; Gjorup I; Worning H
Scand J Gastroenterol; 1991 Jun; 26(6):627-37. PubMed ID: 1713709
[TBL] [Abstract][Full Text] [Related]
44. Cholecystokinetic and pancreozymic effect of O-sulfated gastrin compared with nonsulfated gastrin and cholecystokinin.
Cantor P; Petronijevic L; Pedersen JF; Worning H
Gastroenterology; 1986 Nov; 91(5):1154-63. PubMed ID: 3758607
[TBL] [Abstract][Full Text] [Related]
45. Gallbladder responses to modified sham feeding: effects of the composition of a meal.
Witteman BJ; Jebbink MC; Hopman WP; Masclee AM; Lamers CB; Jansen JB
J Hepatol; 1993 Nov; 19(3):465-9. PubMed ID: 8151108
[TBL] [Abstract][Full Text] [Related]
46. Altered sensitivity of the gallbladder to cholecystokinin octapeptide in irritable bowel syndrome.
Kellow JE; Miller LJ; Phillips SF; Zinsmeister AR; Charboneau JW
Am J Physiol; 1987 Nov; 253(5 Pt 1):G650-5. PubMed ID: 3318495
[TBL] [Abstract][Full Text] [Related]
47. Effect of intravenous fat on cholecystokinin secretion and gallbladder motility in man.
de Boer SY; Masclee AA; Jebbink MC; Schipper J; Jansen JB; Lamers CB
JPEN J Parenter Enteral Nutr; 1992; 16(1):16-9. PubMed ID: 1738213
[TBL] [Abstract][Full Text] [Related]
48. Gallbladder emptying, plasma levels of estradiol and progesterone, and cholecystokinin secretion in liver cirrhosis.
Pompili M; Rapaccini GL; Caturelli E; Curró D; Montuschi P; D'Amato M; Aliotta A; Grattagliano A; Cedrone A; Anti M
Dig Dis Sci; 1995 Feb; 40(2):428-34. PubMed ID: 7851211
[TBL] [Abstract][Full Text] [Related]
49. Effect of circulating peptide YY on gallbladder emptying in humans.
Hoentjen F; Hopman WP; Jansen JB
Scand J Gastroenterol; 2001 Oct; 36(10):1086-91. PubMed ID: 11589384
[TBL] [Abstract][Full Text] [Related]
50. Effect of equimolar amounts of long-chain triglycerides and medium-chain triglycerides on plasma cholecystokinin and gallbladder contraction.
Hopman WP; Jansen JB; Rosenbusch G; Lamers CB
Am J Clin Nutr; 1984 Mar; 39(3):356-9. PubMed ID: 6695835
[TBL] [Abstract][Full Text] [Related]
51. Acalculous biliary pain: cholecystectomy alleviates symptoms in patients with abnormal cholescintigraphy.
Yap L; Wycherley AG; Morphett AD; Toouli J
Gastroenterology; 1991 Sep; 101(3):786-93. PubMed ID: 1860640
[TBL] [Abstract][Full Text] [Related]
52. Plasma cholecystokinin, plasma peptide YY and gallbladder motility in patients with slow transit constipation: effect of intestinal stimulation.
Mollen RM; Hopman WP; Kuijpers HH; Jansen JB
Digestion; 2000; 62(2-3):185-93. PubMed ID: 11025367
[TBL] [Abstract][Full Text] [Related]
53. Cholestyramine influences meal-stimulated pancreaticobiliary function and plasma cholecystokinin independent of gastric emptying and food digestion.
Thimister PW; Hopman WP; Loualidi A; Rosenbusch G; Willems HL; Trijbels FJ; Jansen JB
Scand J Gastroenterol; 1997 Aug; 32(8):778-84. PubMed ID: 9282969
[TBL] [Abstract][Full Text] [Related]
54. Gallbladder function and gastric liquid emptying in achalasia.
Annese V; Caruso N; Accadia L; Gabbrielli A; Modoni S; Frusciante V; Federici T
Dig Dis Sci; 1991 Aug; 36(8):1116-20. PubMed ID: 1864206
[TBL] [Abstract][Full Text] [Related]
55. Gallbladder motility before and after Billroth II gastric resection.
Chiloiro M; Pezzolla F; Riezzo G; Maselli MA; Lorusso D
Neurogastroenterol Motil; 1995 Sep; 7(3):145-9. PubMed ID: 8536158
[TBL] [Abstract][Full Text] [Related]
56. Large and small forms of cholecystokinin in human plasma: measurement using high pressure liquid chromatography and radioimmunoassay.
Maton PN; Selden AC; Chadwick VS
Regul Pept; 1982 Oct; 4(5):251-60. PubMed ID: 7178534
[TBL] [Abstract][Full Text] [Related]
57. Cholecystokinin does not stimulate prosomatostatin-derived peptides in man.
Liddle RA; Ensinck JW
J Clin Endocrinol Metab; 1990 May; 70(5):1403-7. PubMed ID: 1970830
[TBL] [Abstract][Full Text] [Related]
58. Role of CCK in regulation of pancreaticobiliary functions and GI motility in humans: effects of loxiglumide.
Schmidt WE; Creutzfeldt W; Schleser A; Choudhury AR; Nustede R; Höcker M; Nitsche R; Sostmann H; Rovati LC; Fölsch UR
Am J Physiol; 1991 Feb; 260(2 Pt 1):G197-206. PubMed ID: 1996640
[TBL] [Abstract][Full Text] [Related]
59. Radiation-dose calculation for five Tc-99m IDA hepatobiliary agents.
Brown PH; Krishnamurthy GT; Bobba VR; Kingston E; Turner FE
J Nucl Med; 1982 Nov; 23(11):1025-30. PubMed ID: 6897074
[TBL] [Abstract][Full Text] [Related]
60. Coffee stimulation of cholecystokinin release and gallbladder contraction in humans.
Douglas BR; Jansen JB; Tham RT; Lamers CB
Am J Clin Nutr; 1990 Sep; 52(3):553-6. PubMed ID: 2393014
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
